PHARMACEUTICALLY EFFECTIVE COMPOUNDS INHIBITING SELECTIVELY THE MYOSIN 2 ISOFORMS
The present invention relates to compounds of formula (I) or (II), pharmaceutically acceptable salts thereof, solvates, tautomers, and stereoisomers including enantiomers, diastereomers, racemic mixtures, mixtures of enantiomers, or combinations thereof, and the pharmaceutical uses of the compounds..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Europäisches Patentamt - (2021) vom: 05. Feb. Zur Gesamtaufnahme - year:2021 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
MALNASI-CSIZMADIA ANDRAS [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2021-02-05, Last update posted on www.tib.eu: 2022-10-22, Last updated: 2023-02-09 |
|---|
| Patentnummer: |
CN112334191 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA014655276 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA014655276 | ||
| 003 | DE-627 | ||
| 005 | 20230504115912.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230215s2021 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA014655276 | ||
| 035 | |a (EPA)CN112334191 | ||
| 035 | |a (EPA)68072842 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a MALNASI-CSIZMADIA ANDRAS |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a PHARMACEUTICALLY EFFECTIVE COMPOUNDS INHIBITING SELECTIVELY THE MYOSIN 2 ISOFORMS |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2021-02-05, Last update posted on www.tib.eu: 2022-10-22, Last updated: 2023-02-09 | ||
| 520 | |a The present invention relates to compounds of formula (I) or (II), pharmaceutically acceptable salts thereof, solvates, tautomers, and stereoisomers including enantiomers, diastereomers, racemic mixtures, mixtures of enantiomers, or combinations thereof, and the pharmaceutical uses of the compounds. | ||
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a C07D: Heterocyclic compounds (macromolecular compounds c08) | |
| 650 | 4 | |a che | |
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a GYIMESI MATE |4 aut | |
| 700 | 0 | |a SZABO ANDRAS |4 aut | |
| 700 | 0 | |a HARI PETER |4 aut | |
| 700 | 0 | |a KUMAR SUTHAR SHARAD |4 aut | |
| 700 | 0 | |a KOVACS MIHALY |4 aut | |
| 700 | 0 | |a HORVATH ADAM ISTVAN |4 aut | |
| 700 | 0 | |a PENZES MATE |4 aut | |
| 700 | 0 | |a LOERINCZ ISTVAN |4 aut | |
| 700 | 0 | |a JOSEPH ROPARCI |4 aut | |
| 700 | 0 | |a ZOLTAN SZONYEGO |4 aut | |
| 700 | 0 | |a ZOLTAN SIMON |4 aut | |
| 700 | 0 | |a LEGRO WIGNER |4 aut | |
| 700 | 0 | |a SANDO BATORY |4 aut | |
| 700 | 0 | |a VARJAK HORVATH |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2021) vom: 05. Feb. |
| 773 | 1 | 8 | |g year:2021 |g day:05 |g month:02 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/68072842/publication/CN112334191A1?q=CN112334191 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | u | w | |j 2021 |b 05 |c 02 |
| 951 | |a AR | ||
| 952 | |j 2021 |b 05 |c 02 | ||